Business Context and Reporting Period
Company: MILESTONE SCIENTIFIC INC.
Filing Type: Form 8-K (Current Report)
Date of Report: September 27, 2024
Reporting Period: Single event date (September 27, 2024)
Business Context: The registrant is a Delaware corporation with principal executive offices in Roseland, NJ. Its common stock trades on the NYSE American under the symbol "MLSS". This filing serves as a Regulation FD disclosure regarding the publication of an investor presentation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the availability of an investor presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The sole material event is the dissemination of non-registered investor presentation materials to the public.
Guidance, Outlook, and Risks
- Management Commentary: The Company published an investor presentation on September 27, 2024, available at https://tffpharma.com/investors/.
- Legal Status of Information: The information contained in the investor presentation (Exhibit 99.1) is furnished pursuant to Item 7.01 and is explicitly not deemed "filed" under the Securities Exchange Act of 1934. It is not subject to Section 18 liabilities and is not incorporated by reference into other filings.
- Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K, other than the standard legal disclaimer regarding the status of the furnished presentation.
Investor Verification Checklist
- Verify the content of the investor presentation attached as Exhibit 99.1, as the 8-K itself contains no financial data.
- Confirm the URL provided (https://tffpharma.com/investors/) for accessing the presentation materials.
- Note that the presentation materials are not legally "filed" and do not carry the same liability protections as formal SEC filings.
- Check subsequent filings (e.g., 10-Q or 10-K) for actual financial metrics and operational updates.